In 1773, John Fothergill 4 described 16 patients with TN. In 1966, Jannetta and Rand 6 proposed that the origin of TN rests in the compression of the trigeminal nerve by small blood vessels near the brainstem. Since that time, MVD has become a mainstay in the management of this painful condition.
In its classic or typical form, TN involves a unilateral, lancinating, electrical pain in one or more of the trigeminal nerve distributions. Patients usually describe typical trigger points on the face and triggering stimuli or activities. The pain generally has a memorable onset, may be positional in nature, and has variable periods of remission. Most patients describe some modicum of pain relief from medications that include carbamazepine, phenytoin, or baclofen.
Atypical TN denotes a syndrome in which patients describe unilateral pain which, although it is in a trigeminal distribution, is more burning or aching in nature. This discomfort may be continuous or nearly continuous and rarely responds to any of the aforementioned medications. Some patients have previously suffered from typical TN, but over the years it has evolved into an atypical condition. These patients may have moved through a stage called transitional TN, which has characteristics of both the typical and atypical disease. The trigeminal pain syndromes were re-cently described by Burchiel and Slavin 3 as a continuum rather than discrete diagnoses, which is consistent with our description of transitional TN.
In this paper we look at the results of 2003 MVDs for typical TN and 672 of these procedures for atypical TN that were performed at the University of Pittsburgh Medical Center before 1996. This helped us to determine the patient characteristics predictive for outcome following MVD and also to assess surgical complication rates in these two populations. In an earlier paper from our institution, investigators reviewed the results of MVD for typical TN. 1 In that paper the authors reviewed 1185 patients who underwent MVD for typical TN between 1972 and 1991 and looked at more than 1 year of follow up in 1155 patients. In our paper we have reviewed an additional 1079 patients who underwent MVD for either typical or atypical TN, and we looked at long-term outcomes in patients for whom 5 or more years of follow-up data were available.
Clinical Material and Methods
The TN database at the University of Pittsburgh was reviewed to identify all patients who underwent MVD for TN before 1996. Previously collected data relating to complications and outcomes were combined with data collected through phone calls to patients to yield the information in this manuscript. Follow up ended in December 2000. All data were analyzed by a statistician (Y.F.C.), who then made graphs of the results. Outcomes were divided into three categories as follows: 1) excellent denoted patients who were pain free off medications; 2) good denoted patients with infrequent pain controlled with low-dose medications; and 3) poor described patients with no postsurgical pain relief on or off medications.
Population and Demographics
Between February 1972 and December 1995, 2675 MVDs were performed in 2264 patients for the treatment of TN at the University of Pittsburgh Medical Center. Of these, 2003 procedures were for typical and 672 were for atypical TN (Table 1) . Sixty-one percent of the patients were female. The median age of all patients was 55 years, with typical TN occurring at a median age of 57 (range 5-87 years) and atypical TN at a median age of 46.5 (range 14-81 years). Of patients with typical TN, 4.8% had a family history of the syndrome, whereas only 1.5% with atypical TN had a family history of the disease (Table 2) .
A total of 2003 MVDs for typical TN were performed in 1739 patients, with 240 of them undergoing multiple MVDs. Sixty percent of patients had right-sided pain and 8% had bilateral symptoms. Of the 1795 patients who were treated preoperatively with carbamazepine, medical treatment ultimately failed in 92%. Other aspects of the patients' clinical histories are noted in Table 3 . Five years or more of follow-up data were available in 974 patients (range 5-22.6 years, mean 11.3 years, median 10.5 years).
A total of 672 MVDs for atypical TN were performed prior to 1996 in 537 patients, of whom 114 had multiple MVDs. Fifty percent of patients had right-sided pain and 12.5% had bilateral symptoms. Of the 441 patients who were treated preoperatively with carbamazepine, medical treatment ultimately failed in 96%. Other aspects of the patients' clinical histories are noted in Table 3 . Five or more years of follow-up data were available in 220 patients (range 5-22.2 years, mean 9.8 years, median 7.9 years).
When evaluating the 346 patients who had multiple MVDs at our institution we found that the ratio of typical to atypical TN decreased as the number of MVDs increased. The ratio for single procedures was significantly greater than for multiple procedures (Table 1) . Additionally, we identified eight patients who were initially treated for typical TN who were subsequently treated for atypical TN.
Results

Postoperative Complications
Results of MVD mean nothing if the surgical risks associated with the procedure are excessive. Complications for MVD in patients with typical and atypical TN are shown in Table 4 . The most notable difference between the complications for typical and atypical TN surgery was the much higher rate of significant meningismus.
Immediate Postoperative Pain Relief
Typical TN. As shown in Table 5 , excellent immediate postoperative pain relief was achieved in 80.3% of patients who underwent MVD for typical TN, 16.5% received good (partial) relief, and 3.2% had no response: a 96.8% signifi- cant pain reduction with surgery. When patients available for 5 years or more of follow up were studied separately for their immediate postoperative results, 84.1% had experienced excellent results, 14.1% had a good result, and 1.8% had no surgical response: a 98.2% significant pain reduction with surgery.
Atypical TN. Excellent immediate postoperative pain relief was achieved in 46.9% of patients who underwent MVD for atypical TN, 39.7% received good relief, and 13.4% had no response: an 86.6% significant pain reduction with surgery. When patients available for 5 years or more of follow up were studied separately for their immediate postoperative results, 58.2% had experienced excellent results, 33.2% had a good result, and 8.6% had no surgical response: a 91.4% significant pain reduction with surgery.
Long-Term Postoperative Pain Relief
Typical TN. As shown in Table 5 , long-term excellent pain relief in the patients available for follow up was achieved in 73.7%, good pain relief was attained in 6.8%, and 19.5% had no long-term pain relief. Therefore, significant pain relief in this population declined from 98.2% immediately postoperatively to 80.5% at 5 years or more after MVD.
Atypical TN. Long-term excellent pain relief in patients available for follow up was achieved in 34.7%, good pain relief was attained in 16.4%, and 48.9% had no long-term pain relief. Therefore, significant pain relief in this population declined from 91.4% immediately postoperatively to 51.1% at 5 years or more after MVD.
In addition to analyzing overall outcomes, both immediate and long-term, in patients with typical and atypical TN, we investigated whether outcomes in our patient population differed based on presenting components of the clinical history. These included memorable onset of pain, presence of a trigger point, history of MVD, previous destructive procedure for management of TN, presence of a preoperative trigeminal distribution sensory loss, family history, and presence of bilateral pain. Findings for typical TN are summarized in Table 6 and for atypical TN in Table 7 .
The majority of patients had been treated with carbamazepine before undergoing MVD. We found that treatment in 92% of patients who had taken carbamazepine for typical TN had failed before MVD, whereas carbamazepine failed in 96% of patients with atypical TN before MVD.
Trends were similar when immediate 30-day postoperative results were compared with long-term results at 5 years or more in all patients who underwent MVD and those in the subpopulation in whom 5 years or more of follow-up data were available.
Along with these findings, a review of the data demonstrated that bilateral tic was a negative predictor for longterm pain control following MVD for typical TN (p = 0.001), as was preoperative sensory loss for atypical TN (p Ͻ 0.05). Previous MVD or destructive lesions were negative predictors for immediate postoperative pain relief following surgery for typical TN (p Ͻ 0.05), but not for long-term outcomes. For typical TN, trigger points were positive predictors for better long-term outcome (p Ͻ 0.05). Memorable onset of pain and trigger points were positive
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Outcome predictors in typical and atypical trigeminal neuralgia 529 predictors for better immediate postoperative pain relief for both typical and atypical TN (p Ͻ 0.05).
Discussion
As has been previously discussed, MVD is a safe and effective treatment for typical TN. 1 Our results for postoperative pain relief after MVD for typical TN are similar to those previously reported from our institution.
1 Our longterm outcomes are slightly better. This in part reflects the fact that we included 27 patients who underwent more than two operations for recurrent or residual pain.
In our review of factors predictive of immediate postoperative relief after surgery for typical TN we found that trigger points and memorable onset of pain were positive predictors of excellent outcomes, whereas preoperative sensory loss, previous MVD, and previous destructive le- sioning were negative predictors. Only trigger points were positive predictors for good long-term outcomes, whereas bilateral pain was a negative predictor of excellent longterm outcomes. This is consistent with a previous review of bilateral tic pain at our institution, 8 from which we inferred that venous pathology is more common in these cases and that when the offending vessel is venous, recurrence is more likely. 1, 5, 7, 11 The most striking finding in this study was the extremely poor results for atypical TN. Despite postoperative pain relief in 86% of patients, only 51% had long-term relief and only 35% had excellent long-term outcomes. Similarly to typical TN, memorable onset and trigger points were positive predictors for excellent postoperative relief after MVD for atypical TN. Preoperative sensory loss was a negative predictor for long-term pain relief.
These results are consistent with our belief that there is a group of patients along the continuum of typical to atypical TN who may benefit from MVD. We refer to these as transitional patients. They are characterized as having the constant burning pain of atypical TN but also some components of typical TN, such as trigger points for sudden memorable onsets of their pain. Sensory loss would be more consistent with patients who have progressed farther along the continuum. 3 We found that the majority of patients who underwent MVD had taken carbamazepine and medical management had failed in these patients prior to surgery. Unfortunately, we do not have good records regarding which patients had had a prior response to carbamazepine. In the future we intend to analyze the role of prior carbamazepine responsiveness as a predictive factor.
Conclusions
As we have previously asserted, MVD is a safe and effective treatment for typical TN. As a rule, MVD for atypical TN has a poor outcome, with 50% of patients experiencing recurrent pain that is poorly controlled. We infer from the data that there is a subset of patients with atypical TN who have better outcomes. We plan to advance this work by reviewing the group of patients whom we refer to as having transitional TN to determine if they have better long-term outcomes.
